163082-04-0

Basic information

• Product Name: (1R,4S,5S,6R)-3-bromo-4,5-(isopropylidenedioxy)-7-(4'-methylphenylsulfonyl)-7-azabicyclo<4.1.0>hept-2-ene
• Synonyms: (1R,4S,5S,6R)-3-bromo-4,5-(isopropylidenedioxy)-7-(4'-methylphenylsulfonyl)-7-azabicyclo<4.1.0>hept-2-ene
• CAS NO: 163082-04-0
• Molecular Weight: 400.293
• Mol File: 163082-04-0.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (1R,4S,5S,6R)-3-bromo-4,5-(isopropylidenedioxy)-7-(4'-methylphenylsulfonyl)-7-azabicyclo<4.1.0>hept-2-ene(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,4S,5S,6R)-3-bromo-4,5-(isopropylidenedioxy)-7-(4'-methylphenylsulfonyl)-7-azabicyclo<4.1.0>hept-2-ene(163082-04-0)
• EPA Substance Registry System: (1R,4S,5S,6R)-3-bromo-4,5-(isopropylidenedioxy)-7-(4'-methylphenylsulfonyl)-7-azabicyclo<4.1.0>hept-2-ene(163082-04-0)

Safety Data

• Hazardous Substances Data: 163082-04-0(Hazardous Substances Data)

Upstream product

• 183902-27-4 (3aS,4S,5R,7aS)-5-Azido-7-bromo-2,2-dimethyl-3a,4,5,7a-tetrahydro-benzo[1,3]dioxol-4-ol 
• 183674-17-1 (1R,2S,5S,6R)-3,6-dibromo-1,2-O-isopropylidenecyclohex-3-ene-1,2,5-triol 
• 130669-75-9 (3aS,7aS)-4-bromo-2,2-dimethyl-3a,7a-dihydro-1,3-benzodioxole 
• 67451-62-1 cis-(1S,2S)-1,2-dihydroxy-3-bromocyclohexa-3,5-diene 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 350032-43-8 N-[7-bromo-5S-(7-bromo-4S-hydroxy-2,2-dimethyl-3Ra,4S,5S,7a-tetrahydro-benzo[1S,3R]dioxol-5S-ylamino)-2,2-dimethyl-3Ra,4S,5S,7a-tetrahydro-benzo[1S,3R]dioxol-4S-yl]-4-methyl-benzenesulfonamide 
• 1349901-46-7 C₂₁H₃₂N₂O₇S 
• 1196491-13-0 ethyl (3R,4R,5S)-5-((tert-butoxycarbonyl)amino)-3-hydroxy-4-(4-methylphenylsulfonamido)cyclohex-1-ene carboxylate 
• 1196491-09-4 ethyl (3aR,4R,6S,7R,7aS)-6-[(tert-butoxycarbonyl)amino]-2,2-dimethyl-7-{[(4-methylphenyl)sulfonyl]amino}hexahydro-1,3-benzodioxole-4-carboxylate 
• 1196491-05-0 ethyl (3aR,6S,7R,7aS)-6-[(tert-butoxycarbonyl)amino]-2,2-dimethyl-7-{[(4-methylphenyl)sulfonyl]amino}-3a,6,7,7a-tetrahydro-1,3-benzodioxole-4-carboxylate 
• 1196491-69-6 tert-butyl ((3aS,4R,5S,7aS)-7-bromo-2,2-dimethyl-4-([(4-methylphenyl)sulfonyl]amino)-3a,4,5,7a-tetrahydro-1,3-benzodioxol-5-yl)carbamate 
• 1349901-42-3 C₁₆H₂₁BrN₂O₄S 
• 1196491-67-4 N-[(3aS,4R,5S,7aS)-5-azido-7-bromo-2,2-dimethyl-3a,4,5,7a-tetrahydro-1,3-benzodioxol-4-yl]-4-methylbenzenesulfonamide 
• 1106677-16-0 N-((3aS,4R,5S,7aS)-7-bromo-5-hydroxy-2,2-dimethyl-3a,4,5,7a-tetrahydro-benzo[1,3]dioxol-4-yl)-4-methyl-benzenesulfonamide 
• 163082-18-6 (3'aS,4'R,5'R,7'aR)-7-Ethoxymethoxy-2',2'-dimethyl-4'-(toluene-4-sulfonylamino)-3'a,4',5',7'a-tetrahydro-[5,5']bi[benzo[1,3]dioxolyl]-6-carboxylic acid diethylamide 
• 172483-32-8 Acetic acid (1R,2S,3S,4S,5R,6R)-2,3,4-triacetoxy-6-benzo[1,3]dioxol-5-yl-5-methoxycarbonylamino-cyclohexyl ester 
• 172483-27-1 N-[(1R,2R,5R,6S)-2-(1,3-benzodioxol-5-yl)-5,6-(isopropylidenedioxy)cyclohex-3-en-1-yl]-N-(methoxycarbonyl)-4-methylbenzenesulfonamide 

Relevant articles and documents

Several generations of chemoenzymatic synthesis of oseltamivir (Tamiflu): Evolution of strategy, quest for a process-quality synthesis, and evaluation of efficiency metrics

Four generations of chemoenzymatic approaches to oseltamivir are presented. The first two generations relied on the use of cyclohexadiene-cis-diol derived enzymatically from bromobenzene. The third and fourth generation used the corresponding diol obtaine

Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives.

Biocatalytic approaches have yielded efficient total syntheses of the major Amaryllidaceae alkaloids, all based on the key enzymatic dioxygenation of suitable aromatic precursors. This paper discusses the logic of general synthetic design for lycoricidine, narciclasine, pancratistatin, and 7-deoxypancratistatin. Experimental details are provided for the recently accomplished syntheses of narciclasine, ent-7-deoxypancratistatin, and 10b-epi-deoxypancratistatin via a new and selective opening of a cyclic sulfate over aziridines followed by aza-Payne rearrangement. The structural core of 7-deoxypancratistatin has also been degraded to a series of intermediates in which the amino inositol unit is cleaved and deoxygenated in a homologous fashion. These truncated derivatives and the compounds from the synthesis of the unnatural derivatives have been tested against six important human cancer cell lines in an effort to further develop the understanding of the mode of action for the most active congener in this group, pancratistatin. The results of the biological activity testing as well as experimental, spectral, and analytical data are provided in this manuscript for all relevant compounds.

Structure assignment of aminoconduritols by 15N NMR correlation spectroscopy; synthesis of a positional isomer of 7-deoxypancratistatin

A positional isomer of 7-deoxypancratistatin was synthesized in 12 steps from epoxyaziridines 4 and 5. An intermolecular opening of the aziridine rather than the epoxide in the early stages of the synthesis led to 13, which did not match the properties of